Want to see HK:8189 full AI Analyst Report?

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) Financial Statements

2 Followers

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Financial Overview

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H's market cap is currently HK$376.54M. The company's EPS TTM is HK$-0.0122; its P/E ratio is -15.47; Tianjin TEDA Biomedical Engineering Co. Ltd. Class H is scheduled to report earnings on August 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 509.43M	¥ 385.48M	¥ 398.00M	¥ 403.73M	¥ 476.38M
Gross Profit	¥ 34.75M	¥ 16.97M	¥ 21.37M	¥ 14.82M	¥ 45.60M
Operating Income	¥ -23.57M	¥ -28.38M	¥ -9.83M	¥ -24.41M	¥ -18.39M
EBITDA	¥ -14.32M	¥ -20.19M	¥ 4.79M	¥ -2.26M	¥ -29.86M
Net Income	¥ -88.47M	¥ -27.80M	¥ -20.16M	¥ -27.45M	¥ -42.26M
Balance Sheet
Cash & Short-Term Investments	¥ 29.22M	¥ 25.40M	¥ 5.93M	¥ 9.55M	¥ 29.78M
Total Assets	¥ 264.96M	¥ 332.53M	¥ 303.28M	¥ 337.20M	¥ 347.60M
Total Debt	¥ 109.79M	¥ 159.92M	¥ 83.56M	¥ 102.61M	¥ 90.34M
Net Debt	¥ 80.56M	¥ 134.52M	¥ 77.62M	¥ 89.16M	¥ 63.90M
Total Liabilities	¥ 262.22M	¥ 304.09M	¥ 238.70M	¥ 253.48M	¥ 237.24M
Stockholders' Equity	¥ 12.23M	¥ 22.15M	¥ 49.95M	¥ 70.11M	¥ 100.78M
Cash Flow
Free Cash Flow	¥ -62.84M	¥ -28.83M	¥ -15.62M	¥ -21.62M	¥ -40.38M
Operating Cash Flow	¥ -54.58M	¥ -26.27M	¥ -13.15M	¥ -12.82M	¥ -6.68M
Investing Cash Flow	¥ 31.36M	¥ -37.24M	¥ -467.44K	¥ -12.93M	¥ -8.51M
Financing Cash Flow	¥ 27.03M	¥ 82.95M	¥ 12.73M	¥ 6.17M	¥ 28.10M

Currency in CNY

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Earnings and Revenue History

Income Statement >

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Debt to Assets

Balance Sheet >

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Cash Flow

Cash Flow >

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Forecast EPS vs Actual EPS

Earnings >